{"entity":{"type":"insider","cik":"0001551439","url":"/insider/0001551439","json_url":"/insider/0001551439.json","name":"Franken Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2014-12-12","last":"2015-12-14","span_basis":"filed_date"},"name_variants":[{"name":"Franken Michael","source":"filing","n_filings":6,"first_seen":"2014-12-12","last_seen":"2015-12-14"}],"transactions":[{"id":8878345,"accession":"0001179110-15-016196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-016196","line_url":"/filing/0001179110-15-016196#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":520.0,"shares_display":"520","price_per_share":15.84,"price_display":"15.84","price_state":"stated","total_value":8236.8,"total_display":"8,236.80","total_whole":"8,237","shares_owned_after":37968.0,"shares_owned_after_display":"37,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8743704,"accession":"0001104659-15-065174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-065174","line_url":"/filing/0001104659-15-065174#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":513.0,"shares_display":"513","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":9705.96,"total_display":"9,705.96","total_whole":"9,706","shares_owned_after":38488.0,"shares_owned_after_display":"38,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-15","scope":"insider"},{"id":8529625,"accession":"0001179110-15-012119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-012119","line_url":"/filing/0001179110-15-012119#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.36,"price_display":"22.36","price_state":"stated","total_value":447200.0,"total_display":"447,200.00","total_whole":"447,200","shares_owned_after":39001.0,"shares_owned_after_display":"39,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-14","scope":"insider"},{"id":8810524,"accession":"0001179110-15-009761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-009761","line_url":"/filing/0001179110-15-009761#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":512.0,"shares_display":"512","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":11453.44,"total_display":"11,453.44","total_whole":"11,453","shares_owned_after":39001.0,"shares_owned_after_display":"39,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"},{"id":8862580,"accession":"0001179110-15-004846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-004846","line_url":"/filing/0001179110-15-004846#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":512.0,"shares_display":"512","price_per_share":14.71,"price_display":"14.71","price_state":"stated","total_value":7531.52,"total_display":"7,531.52","total_whole":"7,532","shares_owned_after":39513.0,"shares_owned_after_display":"39,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-13","scope":"insider"},{"id":6694600,"accession":"0001179110-14-018052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-018052","line_url":"/filing/0001179110-14-018052#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001551439","owner_name":"Franken Michael","owner_display_name":"Franken Michael","owner_url":"/insider/0001551439","role":"Officer (President, Biosimilars Busines)","role_mark":"O","role_mark_label":"Officer (President, Biosimilars Busines)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Biosimilars Busines","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2047.0,"shares_display":"2,047","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":25157.63,"total_display":"25,157.63","total_whole":"25,158","shares_owned_after":22953.0,"shares_owned_after_display":"22,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Officer (President, Biosimilars Busines)","n_filings":6,"first_seen":"2014-12-12","last_seen":"2015-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551439","retrieved_at":"2026-08-24T21:56:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}